Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0605
E

Unnecessary Use of Antipsychotic Medications for Residents with Dementia

Antlers, Oklahoma Survey Completed on 06-19-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure that antipsychotic medications were only prescribed for appropriate, approved diagnoses. Two residents were identified as receiving Quetiapine, an antipsychotic medication, for diagnoses of dementia and Alzheimer's disease, which are not approved indications for this medication according to facility policy. One resident had an order for Quetiapine for unspecified mild dementia with behavioral disturbance, and the DON confirmed that the resident did not have a diagnosis that justified the use of this medication. The medication order had been continued from the resident's admission without proper review for appropriateness. Another resident was prescribed Quetiapine for Alzheimer's disease, unspecified. The DON acknowledged that Quetiapine is intended for specific mental health diagnoses and not for dementia, and stated that the order should have been changed. The resident was receiving the medication due to behavioral issues, such as removing their belt and attempting to hit others, but there was no documentation of an approved diagnosis for antipsychotic use. The facility's policy requires antipsychotic medications to be used only when necessary for specific, indicated conditions, which was not followed in these cases.

An unhandled error has occurred. Reload 🗙